New product aims to prevent DVT and PE

Publication date: Thursday, 07 February 2019
A new simple device has been designed to improve venous blood flow of people when seated and to help in the prevention, care and treatment of deep vein thrombosis and pulmonary embolism.
The RBR legflow™ was created with the input of Professor Richard Beasley, director of the Medical Research Institute of New Zealand (MRINZ) and a world authority on respiratory medicine who has undertaken ground-breaking research of ‘e-thrombosis’.
He said: “Research from the MRINZ has shown that this device markedly increases lower limb venous blood flow, thereby potentially reducing the risk of blood clots, in people who sit for long periods at work or with long distance air travel.”
As part of its design, the RBR legflow™ is manufactured with an antimicrobial ingredient which offers excellent protection against bacteria, biofilm, fungi and mould, and has no adverse effect on the RBR legflow™ properties. This antimicrobial element remains effective for the lifetime of the product and all the active components used are approved by the FDA and EPA. The aim is to dramatically reduce the risk of any cross-infection.
Thrombosis key facts:
|
More information For more details on this product visit the RBR Active website at https://www.rbractive.com/ |
READ MORE ARTICLES
CVD prevention opportunities here and now
Updated NICE guidance will help people in hospital most at risk of VTE